Alphamab Oncology Files HKEX Disclosure on Repurchase of 560,000 Shares at HK$9.39 Each

Reuters
2025.11.07 11:12
portai
I'm PortAI, I can summarize articles.

Alphamab Oncology has disclosed to the Hong Kong Stock Exchange the repurchase of 560,000 ordinary shares at an average price of HKD 9.39 each. This information was filed in a Next Day Disclosure Return.

Alphamab Oncology has filed a Next Day Disclosure Return to the Hong Kong Stock Exchange, reporting the repurchase of 560,000 ordinary shares at a volume-weighted average price of HKD 9.3946 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer